Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical Industries has submitted a quarterly confirmation certificate from its Registrar & Share Transfer Agent, MUFG Intime India Pvt. Ltd. The certificate, dated April 3, 2026, is filed under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. It confirms that all securities received from depository participants for dematerialisation during the quarter ended March 31, 2026 (Q4 FY2026) were duly processed (accepted or rejected) and listed on the stock exchanges. The RTA also confirmed that physical share certificates received for demat were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's records within the prescribed timelines.
This is a routine quarterly regulatory compliance filing with no material impact on shareholders, business operations, or stock price. It simply confirms that the company's share transfer process is functioning normally.